Ethyl (2R,4R)-4-Methyl-2-Piperidinecarboxylate CAS 74892-82-3 Argatroban Intermedju Purità Għolja
Provvista tal-Manifattur Argatroban Intermedji Relatati:
Etil (2R,4R)-4-Methyl-2-Piperidinecarboxylate CAS 74892-82-3
N-Nitro-1,2,3,4-tetradehydro Argatroban Ethyl Ester CAS 74874-09-2
3-Methyl-8-Quinolinesulphonyl Klorur CAS 74863-82-4
Argatroban Monohydrate CAS 141396-28-3
Argatroban Anhydrous CAS 74863-84-6
Isem Kimiku | Etil (2R,4R)-4-Methyl-2-Piperidinecarboxylate |
Sinonimi | Etil (2R,4R)-4-Methylpipecolate;(2R,4R)-4-Methyl-2-Piperidinecarboxylate;(2R,4R)-Etil 4-Methylpiperidine-2-Carboxylate;Etil-(2R,4R)-4-Methylpiperidine-2-Carboxylate |
Numru CAS | 74892-82-3 |
Numru CAT | RF-PI267 |
Status tal-istokk | Fil-Ħażna, Skala ta' Produzzjoni Sa Tunnellati |
Formula Molekulari | C9H17NO2 |
Piż Molekulari | 171.24 |
Kundizzjoni tat-Tbaħħir | Mibgħut Taħt Temperatura Ambjentali |
Brand | Ruifu Kimika |
Oġġett | Speċifikazzjonijiet |
Dehra | Likwidu ċar għal isfar ċar |
Diastereoisomer | ≤1.0% |
Purità / Metodu ta 'Analiżi | ≥98.0% (GC) |
Metalli Tqil | ≤20ppm |
Standard tat-Test | Standard tal-Intrapriża |
Użu | Argatroban Intermedju (CAS 74863-84-6) |
Pakkett: Flixkun, Barmil, 25kg/Barrel, jew skond il-ħtieġa tal-klijent.
Kundizzjoni tal-Ħżin:Aħżen f'kontenituri ssiġillati f'post frisk u niexef;Ipproteġi mid-dawl, l-umdità u l-infestazzjoni tal-pesti.
![1](https://a395.goodao.net/uploads/15.jpg)
![](https://a395.goodao.net/uploads/23.jpg)
Shanghai Ruifu Chemical Co., Ltd hija l-manifattur u l-fornitur ewlieni ta 'Ethyl (2R,4R)-4-Methyl-2-Piperidinecarboxylate (CAS: 74892-82-3) bi kwalità għolja.Ethyl (2R,4R)-4-Methyl-2-Piperidinecarboxylate (CAS: 74892-82-3) huwa intermedju tipikament fis-sintesi ta' Argatroban Monohydrate (CAS 141396-28-3) jew Argatroban (CAS 74863-84-6). ).
Argatroban Monohydrate huwa inibitur speċifiku tat-trombina, li huwa antikoagulant mhux eparina, jipprevjeni l-formazzjoni ta 'trombi.Argatroban huwa antikoagulant li huwa inibitur dirett tat-trombina ta 'molekula żgħira.Fl-2000, argatroban kien liċenzjat mill-Food and Drug Administration (FDA) għal profilassi jew trattament ta 'trombożi f'pazjenti bi tromboċitopenja indotta mill-eparina (HIT).